• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白H2A第40位丝氨酸上的O-连接N-乙酰葡糖胺化促进三阴性乳腺癌的增殖和侵袭。

O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer.

作者信息

Uno Yoko, Hayakawa Koji

机构信息

Laboratory of Genetics, Faculty of Veterinary Medicine, Okayama University of Science, Imabari-shi, Ehime, 7948555, Japan.

出版信息

Sci Rep. 2025 Mar 24;15(1):10170. doi: 10.1038/s41598-025-95394-z.

DOI:10.1038/s41598-025-95394-z
PMID:40128346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11933395/
Abstract

Triple-negative breast cancer (TNBC) is characterized by resistance to conventional treatment and a poor prognosis. The O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins has been reported to affect cancer progression. However, the key O-GlcNAc proteins involved in TNBC phenotypes remain unclear. Our previous study demonstrated that serine 40 of histone H2A was modified by O-GlcNAcylation (H2AS40Gc). Since S40 is located inside the globular domain of H2A, H2AS40Gc may be involved in the regulation of gene expression by altering chromatin conformation and could serve as the molecular basis for TNBC. The present study showed that H2AS40Gc levels were significantly higher in TNBC than in the other breast cancer subtypes. Using TNBC cells in which H2AS40Gc levels were depleted, we found that H2AS40Gc is required to promote cell proliferation and migration. The underlying mechanism of this promotion involves the accumulation of H2AS40Gc in the promoter region of KDM5B, a demethylase for lysine 4 of histone H3 (H3K4) that represses the expression of KDM5B, resulting in increased H3K4 trimethylation and elevated expression of genes related to proliferation and migration. Our findings clearly indicate that H2AS40Gc functions to promote proliferation and migration through KDM5B suppression and provide new insights into potential therapeutic approaches for TNBC.

摘要

三阴性乳腺癌(TNBC)的特点是对传统治疗有抗性且预后较差。据报道,蛋白质的O-连接β-N-乙酰葡糖胺(O-GlcNAc)修饰会影响癌症进展。然而,参与TNBC表型的关键O-GlcNAc蛋白仍不清楚。我们之前的研究表明,组蛋白H2A的丝氨酸40被O-连接N-乙酰葡糖胺化修饰(H2AS40Gc)。由于S40位于H2A的球状结构域内,H2AS40Gc可能通过改变染色质构象参与基因表达调控,并可能作为TNBC的分子基础。本研究表明,TNBC中H2AS40Gc水平显著高于其他乳腺癌亚型。使用H2AS40Gc水平降低的TNBC细胞,我们发现H2AS40Gc是促进细胞增殖和迁移所必需的。这种促进作用的潜在机制涉及H2AS40Gc在KDM5B启动子区域的积累,KDM5B是一种组蛋白H3赖氨酸4(H3K4)的去甲基化酶,可抑制KDM5B的表达,导致H3K4三甲基化增加以及与增殖和迁移相关基因的表达升高。我们的研究结果清楚地表明,H2AS40Gc通过抑制KDM5B发挥促进增殖和迁移的作用,并为TNBC的潜在治疗方法提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/a3dfb68835ba/41598_2025_95394_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/3bb14ecdfcc8/41598_2025_95394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/23c7eac3ec7e/41598_2025_95394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/7a8389d24185/41598_2025_95394_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/361caec4cb95/41598_2025_95394_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/b99353a67505/41598_2025_95394_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/a3dfb68835ba/41598_2025_95394_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/3bb14ecdfcc8/41598_2025_95394_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/23c7eac3ec7e/41598_2025_95394_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/7a8389d24185/41598_2025_95394_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/361caec4cb95/41598_2025_95394_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/b99353a67505/41598_2025_95394_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aeec/11933395/a3dfb68835ba/41598_2025_95394_Fig6_HTML.jpg

相似文献

1
O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer.组蛋白H2A第40位丝氨酸上的O-连接N-乙酰葡糖胺化促进三阴性乳腺癌的增殖和侵袭。
Sci Rep. 2025 Mar 24;15(1):10170. doi: 10.1038/s41598-025-95394-z.
2
H2A O-GlcNAcylation at serine 40 functions genomic protection in association with acetylated H2AZ or γH2AX.丝氨酸40位点的H2A O-连接的N-乙酰葡糖胺化与乙酰化的H2AZ或γH2AX协同发挥基因组保护作用。
Epigenetics Chromatin. 2017 Oct 30;10(1):51. doi: 10.1186/s13072-017-0157-x.
3
Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.异常的KDM5B表达通过MALAT1过表达和hsa-miR-448下调促进侵袭性乳腺癌。
BMC Cancer. 2016 Feb 25;16:160. doi: 10.1186/s12885-016-2108-5.
4
Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.组蛋白去甲基化酶 KDM2B 通过抑制 p15INK4B、p16INK4A 和 p57KIP2 的转录来促进三阴性乳腺癌的增殖。
Acta Biochim Biophys Sin (Shanghai). 2018 Sep 1;50(9):897-904. doi: 10.1093/abbs/gmy084.
5
Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.糖 β-N-乙酰葡萄糖胺(GlcNAc)对组蛋白的修饰发生在多个残基上,包括组蛋白 H3 丝氨酸 10 位,并且受到细胞周期调控。
J Biol Chem. 2011 Oct 28;286(43):37483-95. doi: 10.1074/jbc.M111.284885. Epub 2011 Sep 6.
6
JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.JMJD6 通过一种新型的酪氨酸激酶活性调节三阴性乳腺癌细胞中的组蛋白 H2A.X 磷酸化并促进自噬。
Oncogene. 2019 Feb;38(7):980-997. doi: 10.1038/s41388-018-0466-y. Epub 2018 Sep 5.
7
The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.组蛋白H3K4特异性去甲基化酶KDM5B通过不同的植物同源结构域(PHD)指与底物和产物结合。
Cell Rep. 2014 Jan 30;6(2):325-35. doi: 10.1016/j.celrep.2013.12.021. Epub 2014 Jan 9.
8
Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.组蛋白去甲基化酶 KDM5B 的磷酸化及其对三阴性乳腺癌表型的调控。
Sci Rep. 2019 Nov 27;9(1):17663. doi: 10.1038/s41598-019-54184-0.
9
KMT2D-mediated H3K4me1 recruits YBX1 to facilitate triple-negative breast cancer progression through epigenetic activation of c-Myc.KMT2D 通过 H3K4me1 募集 YBX1,通过表观遗传激活 c-Myc 促进三阴性乳腺癌进展。
Clin Transl Med. 2024 Jul;14(7):e1753. doi: 10.1002/ctm2.1753.
10
Knockout of KDM3A in MDA-MB-231 breast cancer cells inhibits tumor malignancy and promotes apoptosis.敲除 MDA-MB-231 乳腺癌细胞中的 KDM3A 可抑制肿瘤恶性程度并促进细胞凋亡。
J Mol Histol. 2024 Feb;55(1):139-148. doi: 10.1007/s10735-023-10178-x. Epub 2024 Jan 2.

本文引用的文献

1
KEGG: biological systems database as a model of the real world.京都基因与基因组百科全书(KEGG):作为现实世界模型的生物系统数据库。
Nucleic Acids Res. 2025 Jan 6;53(D1):D672-D677. doi: 10.1093/nar/gkae909.
2
ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data.ChIP-Atlas 3.0:一个数据挖掘套件,用于探索染色体结构以及大规模调控组数据。
Nucleic Acids Res. 2024 Jul 5;52(W1):W45-W53. doi: 10.1093/nar/gkae358.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
O-GlcNAcylation: the sweet side of epigenetics.O-GlcNAc 修饰:表观遗传学的甜蜜一面。
Epigenetics Chromatin. 2023 Dec 14;16(1):49. doi: 10.1186/s13072-023-00523-5.
5
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer.FN1 介导的天冬氨酸代谢激活促进三阴性和腔 A 型乳腺癌的进展。
Breast Cancer Res Treat. 2023 Oct;201(3):515-533. doi: 10.1007/s10549-023-07032-9. Epub 2023 Jul 17.
6
Update on Classic and Novel Approaches in Metastatic Triple-Negative Breast Cancer Treatment: A Comprehensive Review.转移性三阴性乳腺癌治疗的经典与新方法进展:全面综述
Biomedicines. 2023 Jun 20;11(6):1772. doi: 10.3390/biomedicines11061772.
7
Targeting triple-negative breast cancer: A clinical perspective.靶向三阴性乳腺癌:临床视角。
Oncol Res. 2023 May 24;31(3):221-238. doi: 10.32604/or.2023.028525. eCollection 2023.
8
Role of O-GlcNAcylation in Breast Cancer Biology.O-GlcNAcylation 在乳腺癌生物学中的作用。
Cell Physiol Biochem. 2023 Jun 10;57(3):183-197. doi: 10.33594/000000633.
9
O-GlcNAcylation in cancer development and immunotherapy.O-糖基化在癌症发展和免疫治疗中的作用。
Cancer Lett. 2023 Jul 10;566:216258. doi: 10.1016/j.canlet.2023.216258. Epub 2023 Jun 4.
10
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors.针对癌症治疗的表观遗传调控的小分子抑制剂。
Adv Cancer Res. 2023;158:73-161. doi: 10.1016/bs.acr.2023.01.001. Epub 2023 Feb 16.